Possible Contribution of Multiple Sclerosis Pathology to Treatment-Resistant Schizophrenia: A Case Study. Miura S, Nagaoka A, Hino M, Shishido R, Hatano M, Hosogai Y, Miyahara K, Oba Y, Kaneko K, Kunii Y, et al. Neuropsychopharmacol Rep. 2026 Sep; 46(3):e70158. PMID: 42559701. Abstract CommentRecommendBookmarkWatch
